Whole-plant cannabis extract was more effective against breast cancer cells than pure THC alone

Researchers compared pure THC and a standardized botanical drug preparation in cell culture models and animal models of ER+/PR+, HER2+, and triple-negative breast cancer. Mechanistic studies examined CB2 receptor activation, reactive oxygen species, and alternative targets. Combination studies tested cannabinoids with tamoxifen, lapatinib, and cisplatin.

This is one of the most rigorous preclinical comparisons of pure THC versus whole-plant cannabis in cancer models. The finding that the botanical preparation was more effective and worked through different mechanisms provides scientific support for using standardized whole-plant preparations rather than isolated THC in future cancer research.

The entourage effect has been discussed extensively but rarely tested rigorously in disease models. This study moves beyond anecdotal claims to demonstrate that the entourage effect is measurable in preclinical cancer research, with the botanical preparation not just working better but working differently than pure THC.

This is preclinical research in cell cultures and animal models that may not translate to human breast cancer treatment. The specific compounds responsible for the enhanced effect of the botanical preparation were not identified. The in vivo combination studies showed no interaction with standard therapies, which could limit clinical utility. No human clinical data are available.